Skip to main content
2022 Guide to Patient Support Services


2022 Oncology Guide to Patient Support Services

Bayer Oncology Support Programs

Zero Co-Pay Program
Access Services by Bayer

Bayer offers drug-specific programs to assist patients with access and resources. A complete list of Bayer oncology products and their related assistance programs is provided in the Table.

Bayer Oncology Support Programs

Aliqopa Resource Connections

The Aliqopa Resource Connections, or ARC Program, offers comprehensive access, reimbursement support, and patient assistance services to patients taking Aliqopa to include:

  • Bayer US Patient Assistance Foundation for qualified uninsured or underinsured patients
  • Temporary Patient Assistance Program for patients whose coverage is delayed or who experience a temporary lapse in coverage for Aliqopa
  • Aliqopa $0 Co-Pay Program for eligible patients with commercial insurance.

Click here to learn more or to enroll your patient in the ARC Program, or call 833-254-7672.

Access Services by Bayer

Access Services by Bayer is a free support program available to eligible patients who have been prescribed Nexavar, Nubeqa, Stivarga, Vitrakvi, or Xofigo. Services are drug-specific and may include:

  • Oncology $0 Co-Pay Program assistance for eligible, commercially insured patients
  • Benefit verification/prior authorization denial and appeal information
  • Pharmacy coordination
  • Alternate coverage research for the uninsured and underinsured
  • Access and reimbursement support
  • Referrals to the Bayer US Patient Assistance Foundation for patients who are uninsured or underinsured and meet certain eligibility criteria.

For more information or to enroll your patient in Access Services by Bayer, call 800-288-8374 or see Table for drug-specific links.

Oncology $0 Co-Pay Program

The Oncology $0 Co-Pay Program allows patients to fill their prescriptions with no out-of-pocket costs for eligible, commercially insured patients. Patients may be eligible if they:

  • Are residents of the United States
  • Are over 18 years of age
  • Have commercial health insurance for a portion of their prescription drug cost
  • Are not enrolled in any federal- or state-subsidized healthcare program that covers a portion of prescription drug costs, including Medicare, Medicaid, TRICARE, or any other federal or state healthcare plan, including pharmaceutical assistance programs.

To enroll your patient in the Oncology $0 Co-Pay Program, please see Table for drug-specific links.

TABLE Bayer Oncology Drugs

Patient support programs

Aliqopa (copanlisib) for injection
Relapsed follicular lymphoma in adults after ≥2 systemic therapies
Patient support programs

Nexavar (sorafenib)
Unresectable hepatocellular carcinoma; advanced renal-cell carcinoma; locally recurrent or metastatic, progressive, differentiated thyroid carcinoma refractory to radioactive iodine treatment
Patient support programs

Nubeqa (darolutamide)
Nonmetastatic castration-resistant prostate cancer
Patient support programs

Stivarga (regorafenib)
Metastatic colorectal cancer; unresectable or metastatic gastrointestinal stromal tumors; hepatocellular carcinoma
Patient support programs

Vitrakvi (larotrectinib)
For patients with solid tumors and a NTRK gene fusion without acquired resistance mutation, are metastatic, or if resection is a high risk, who have no alternative treatments or tumor that progressed after treatment. Select patients for therapy based on an FDA-approved test
Patient support program

Report Broken Links

Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?

Help us fix it! Report broken links here.

Report Broken Links

Report Broken Links

*OPM Webpage
Please copy the URL (link) of the OPM webpage you are currently on.
*Broken Link
Please copy the URL (link) to the external webpage that is not displaying content correctly.
Errors include, but are not limited to:
  • "This site can’t be reached"
  • "Hmm. We’re having trouble finding that site."
  • "Hmmm… can't reach this page"
  • "404 Error: Page not found"